×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRX – immuneering corporation - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
04:40 pm
imrx
Immuneering to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
Low
Report
Immuneering to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
3/2
04:05 pm
imrx
Immuneering to Present at the Leerink Global Healthcare Conference
Low
Report
Immuneering to Present at the Leerink Global Healthcare Conference
2/28
02:23 am
imrx
Immuneering Touts 64% 12-Month Survival for Atebimetinib in Pancreatic Cancer, Eyes Phase 3 [Yahoo! Finance]
Low
Report
Immuneering Touts 64% 12-Month Survival for Atebimetinib in Pancreatic Cancer, Eyes Phase 3 [Yahoo! Finance]
2/18
04:37 pm
imrx
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/18
04:05 pm
imrx
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Medium
Report
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
1/11
10:32 am
imrx
Immuneering (IMRX) Valuation After Strong Phase 2a Pancreatic Cancer Data And Planned Phase 3 Transition [Yahoo! Finance]
High
Report
Immuneering (IMRX) Valuation After Strong Phase 2a Pancreatic Cancer Data And Planned Phase 3 Transition [Yahoo! Finance]
1/10
07:02 pm
imrx
Why Immuneering (IMRX) Is Down 29.7% After Positive Phase 2a Pancreatic Cancer Survival Update And What's Next [Yahoo! Finance]
High
Report
Why Immuneering (IMRX) Is Down 29.7% After Positive Phase 2a Pancreatic Cancer Survival Update And What's Next [Yahoo! Finance]
1/8
05:51 pm
imrx
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data [Seeking Alpha]
Low
Report
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2025
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
-0.3%
immuneering corporation - class a
8/13/2025
04:05 pm
imrx
immuneering corporation - class a
IN-LINE
Report
-3.8%
immuneering corporation - class a
5/5/2025
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
-4.8%
immuneering corporation - class a
3/20/2025
04:05 pm
imrx
immuneering corporation - class a
MISS
Report
9.1%
immuneering corporation - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/5
08:45 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Bookman Michael
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Bookman Michael
2/5
08:38 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Brakewood Harold Eugene
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Brakewood Harold Eugene
2/5
08:33 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Hall Brett Matthew
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Hall Brett Matthew
2/5
08:27 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Matushansky Igor
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Matushansky Igor
2/5
08:23 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Morales Mallory
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Morales Mallory
2/5
08:15 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Neufeld Leah R
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Neufeld Leah R
2/5
08:10 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Zeskind Benjamin J.
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Zeskind Benjamin J.
1/22
09:03 am
imrx
Form SCHEDULE 13G/A Immuneering Corp Filed by: Zeskind Benjamin J.
Medium
Report
Form SCHEDULE 13G/A Immuneering Corp Filed by: Zeskind Benjamin J.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: